Exclusive

Publication

Byline

AI Is Shrinking The Cyberattack Window, Raising New Resilience Challenges

New Delhi, Sept. 9 -- Artificial intelligence is changing the nature and speed of cyberattacks, leaving organizations with increasingly shorter windows to detect, contain and recover from breaches, sp... Read More


Samsung makes a desperate Fold8 price drop move to Rs.76,999 hours before Apple Event

India, Sept. 9 -- Samsung has launched an aggressive newspaper advertising campaign for the Galaxy Z Fold8 just before Apple's September 9 event. One advertisement prominently claims that the Galaxy Z... Read More


India's MSMEs Aren't Catching Up. They're Taking Over

New Delhi, Sept. 9 -- Every conversation I have with India's small and medium businesses reinforces the same belief: the founders building India's next wave of growth are not waiting to be discovered.... Read More


Addis Ababa call to action for early warnings to reach every African community

India, Sept. 9 -- Leaders from 50 African nation called for stronger cooperation to ensure people and communities can anticipate climate-related hazards, receive timely warnings and take action before... Read More


Abbott partners with Sengkang General Hospital to advance early detection of muscle loss in Singapore

Singapore, Sept. 9 -- Abbott and Sengkang General Hospital (SKH) have announced a new three-year collaboration to expand muscle health screening, training and public education efforts across Singapore... Read More


Japan's Hodogaya Chemical sets up Nucleic Acid CDMO subsidiary

Singapore, Sept. 9 -- Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In its Mid-term Management Plan "CODE/CHORD 2030,", the company... Read More


Korea Advanced Institute of Science and Technology inks partnership with Thermo Fisher

Singapore, Sept. 9 -- Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHARE Hub, a next-generation autonomous research hub where AI ... Read More


Alebund receives FDA clearance to advance first-in-class AP308 into IgA nephropathy trial

Singapore, Sept. 9 -- Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug application of AP308, a first-in-class engineered recombi... Read More


Kelun-Biotech partner advances ultra-long-acting asthma antibody into Phase III

Singapore, Sept. 9 -- Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting monoclonal antibody targeting thymic stromal lymphopoietin, a... Read More


Accro and Fosun advance oral TYK2/JAK1 inhibitor AC-201 into China Phase II/III vitiligo trial

Singapore, Sept. 9 -- Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-segmental vitiligo following regulatory clearance from the N... Read More